Section Arrow
Quote
IRIX.NASDAQ
- IRIDEX Corp
Quotes are at least 15-min delayed:2026/04/29 04:28 EDT
Pre Market
Last
 --
-- (--)
Bid
1.04
Ask
1.13
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 1.04
-0.04 (-3.70%)
Day High 
1.0652 
Prev. Close
1.08 
1-M High
1.16 
Volume 
138.49K 
Bid
1.04
Ask
1.13
Day Low
1.02 
Open
1.0652 
1-M Low
0.9496 
Market Cap 
18.69M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.05 
20-SMA 1.03 
50-SMA 1.22 
52-W High 1.6481 
52-W Low 0.8688 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.26/--
Enterprise Value
22.52M
Balance Sheet
Book Value Per Share
-0.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
52.68M
Operating Revenue Per Share
3.26
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc.0.5553+0.0422+8.22%-- 
Pre Market 0.5471 -0.0082 -1.48%
BSXBoston Scientific Corp58.45-1.5-2.50%30.9PE
Pre Market 58.54 +0.09 +0.15%
ABTAbbott Laboratories93.86+1.06+1.14%24.95PE
Pre Market 94.2838 +0.4238 +0.45%
MDTMedtronic plc81.9-1.02-1.23%23.16PE
Pre Market 81.85 -0.05 -0.06%
ZBHZimmer Biomet Holdings82.8-9.79-10.57%26.08PE
Pre Market 83 +0.2 +0.24%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.